StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report sent to investors on Thursday morning. The brokerage issued a hold rating on the stock.
China Pharma Stock Down 5.7 %
Shares of NYSE:CPHI traded down $0.01 during midday trading on Thursday, reaching $0.18. The company had a trading volume of 184,586 shares, compared to its average volume of 368,103. The company’s 50 day moving average price is $0.23 and its 200 day moving average price is $0.25. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.84 and a quick ratio of 0.24. China Pharma has a 52-week low of $0.17 and a 52-week high of $1.16.
China Pharma (NYSE:CPHI – Get Free Report) last released its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. China Pharma had a negative net margin of 85.56% and a negative return on equity of 61.46%. The company had revenue of $0.93 million during the quarter.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Articles
- Five stocks we like better than China Pharma
- What is the Hang Seng index?
- Top-Performing Non-Leveraged ETFs This Year
- How Technical Indicators Can Help You Find Oversold Stocks
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
- Most Volatile Stocks, What Investors Need to Know
- Freshworks Stock Soars 50% – Is This the Perfect Entry Point?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
